Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Boehm

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The Laryngoscope|March 31, 2012
Clinical relevance of quality-of-life data in laryngectomized patientsSabine Fahsl, Judith Keszte, Andreas Boehm, et al.
Journal of Psychosocial Oncology|August 16, 2021
Course of social support and associations with distress after partial laryngectomyJulia Roick, Andreas Dietz, Sven Koscielny, et al.
International Journal of Cancer|March 20, 2017
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinomaDana Holzinger, Gunnar Wichmann, Lorena Baboci, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 27, 2024
Patients' Reflections on Treatment Decision After Surgery for Laryngeal CancerSusanne Singer, Julia Roick, Annegret Gose, et al.
Head & Neck|August 22, 2012
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase ISusanne Singer, Juan I Arraras, Ingo Baumann, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Med (New York, N.Y.)|April 12, 2025
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trialAnna Brandt, Konrad Klinghammer, Christoph Schultheiss, et al.
NEJM Evidence|February 6, 2024
High-Dose Glucocorticoids for the Treatment of Sudden Hearing LossStefan K Plontke, Matthias Girndt, Christoph Meisner, et al.
Head & Neck|August 1, 2025
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National StudySusanne Singer, Cecilie Delphin Amdal, Kristin Bjordal, et al.
Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The Laryngoscope|March 31, 2012
Clinical relevance of quality-of-life data in laryngectomized patientsSabine Fahsl, Judith Keszte, Andreas Boehm, et al.
Journal of Psychosocial Oncology|August 16, 2021
Course of social support and associations with distress after partial laryngectomyJulia Roick, Andreas Dietz, Sven Koscielny, et al.
International Journal of Cancer|March 20, 2017
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinomaDana Holzinger, Gunnar Wichmann, Lorena Baboci, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 27, 2024
Patients' Reflections on Treatment Decision After Surgery for Laryngeal CancerSusanne Singer, Julia Roick, Annegret Gose, et al.
Head & Neck|August 22, 2012
Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase ISusanne Singer, Juan I Arraras, Ingo Baumann, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Med (New York, N.Y.)|April 12, 2025
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trialAnna Brandt, Konrad Klinghammer, Christoph Schultheiss, et al.
NEJM Evidence|February 6, 2024
High-Dose Glucocorticoids for the Treatment of Sudden Hearing LossStefan K Plontke, Matthias Girndt, Christoph Meisner, et al.
Head & Neck|August 1, 2025
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National StudySusanne Singer, Cecilie Delphin Amdal, Kristin Bjordal, et al.
Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.
Pageof 5